JP2009517411A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517411A5
JP2009517411A5 JP2008542570A JP2008542570A JP2009517411A5 JP 2009517411 A5 JP2009517411 A5 JP 2009517411A5 JP 2008542570 A JP2008542570 A JP 2008542570A JP 2008542570 A JP2008542570 A JP 2008542570A JP 2009517411 A5 JP2009517411 A5 JP 2009517411A5
Authority
JP
Japan
Prior art keywords
formulation
pyridoxal
phosphate
kit
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008542570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2006/001937 external-priority patent/WO2007059631A1/en
Publication of JP2009517411A publication Critical patent/JP2009517411A/ja
Publication of JP2009517411A5 publication Critical patent/JP2009517411A5/ja
Abandoned legal-status Critical Current

Links

JP2008542570A 2005-11-28 2006-11-28 心血管及び関連病状の処置のための調剤 Abandoned JP2009517411A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74097005P 2005-11-28 2005-11-28
US75385305P 2005-12-23 2005-12-23
US80329806P 2006-05-26 2006-05-26
PCT/CA2006/001937 WO2007059631A1 (en) 2005-11-28 2006-11-28 Selected dosage for the treatment of cardiovascular and related pathologies

Publications (2)

Publication Number Publication Date
JP2009517411A JP2009517411A (ja) 2009-04-30
JP2009517411A5 true JP2009517411A5 (enExample) 2010-01-21

Family

ID=38066885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008542570A Abandoned JP2009517411A (ja) 2005-11-28 2006-11-28 心血管及び関連病状の処置のための調剤

Country Status (5)

Country Link
US (1) US20070149485A1 (enExample)
JP (1) JP2009517411A (enExample)
AU (1) AU2006317440A1 (enExample)
CA (1) CA2632090A1 (enExample)
WO (1) WO2007059631A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196171A2 (en) * 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
EP1610783A2 (en) * 2003-03-27 2006-01-04 Medicure Inc. Modulation of cell death
CN101014357A (zh) * 2004-07-07 2007-08-08 麦迪库瑞国际公司 利用血小板聚集药物的组合疗法
US7705054B1 (en) 2004-10-20 2010-04-27 Vanderbilt University Method of preventing and/or treating oxidant injury in neurodegenerative and oxidative diseases
US8822542B2 (en) 2004-10-20 2014-09-02 Vanderbilt University Isoketal scavengers and mitigation of disorders involving oxidative injury
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US7812037B2 (en) * 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20080213364A1 (en) * 2004-11-26 2008-09-04 Medicure International, Inc. Formulations of Pyridoxal-5'-Phosphate and Methods of Preparation
US20070243249A1 (en) * 2004-11-26 2007-10-18 Friesen Albert D Novel formulation of pyridoxal-5'-phosphate and method of preparation
CA2593793A1 (en) * 2005-01-05 2006-07-13 Medicure International Inc. Compounds and methods for regulating triglyceride levels
CA2503087A1 (en) * 2005-03-30 2006-09-30 Medicure International Inc. Intravenous formulations of pyridoxal 5'-phosphate and method of preparation
WO2011008202A1 (en) * 2009-07-15 2011-01-20 Vanderbilt University Isoketal scavengers and mitigation of disorders involving oxidative injury
ES2902838T3 (es) * 2015-11-17 2022-03-30 Pan Montojo Francisco El ácido glicólico protege contra los infartos
US20200330524A1 (en) * 2016-12-12 2020-10-22 Aobiome Llc Ammonia oxidizing microorganisms for the regulation of blood pressure

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177248A (en) * 1876-05-09 Improvement in drop-lights
US202272A (en) * 1878-04-09 Improvement in awning-frames
US262509A (en) * 1882-08-08 Car-coupling
US215739A (en) * 1879-05-27 Improvement in lifting-handles
US3206463A (en) * 1965-09-14 Pyridoxine aspartate and its process of preparation
US16737A (en) * 1857-03-03 Machine fob
US424069A (en) * 1890-03-25 Blacksmith s forge
US326201A (en) * 1885-09-15 John peeey cobb
US584332A (en) * 1897-06-15 Henry lewis davis
US631726A (en) * 1896-02-19 1899-08-22 James W Leslie Curtain-pole and ring therefor.
US672140A (en) * 1900-08-23 1901-04-16 Harry A Taylor Garment-placket closure.
US729276A (en) * 1902-02-11 1903-05-26 J E Hollenbeck Electric signal.
US739920A (en) * 1902-04-02 1903-09-29 Harry Pauling Apparatus for treating gases.
US720422A (en) * 1902-08-02 1903-02-10 Robert M Green Fire-extinguisher truck.
US732037A (en) * 1903-03-21 1903-06-30 William J Best Folding carrier.
US881864A (en) * 1907-07-02 1908-03-10 Siemens Schuckertwerke Gmbh Means for transmitting power electrically.
US3227724A (en) * 1962-01-16 1966-01-04 Merck & Co Inc Process for preparing 2-methyl-3-hydroxypyridines
GB1228142A (enExample) * 1967-03-31 1971-04-15
GB1172800A (en) * 1967-10-16 1969-12-03 Tanabe Seiyaku Co Novel N-Pyridylmethylidene-Homocysteine Thiolactone Compound and the preparation thereof
US4036844A (en) * 1972-04-04 1977-07-19 Beecham Group Limited Aryloxypyridines
US4032534A (en) * 1973-03-22 1977-06-28 Ferlus-Chimie S.A. Certain 2-(2-thioethyl)thiazolidine-4-carboxylic acids
GB1525885A (en) * 1976-05-11 1978-09-20 Soc D Etudes Prod Chimique Vincamine salt of pyridoxal phosphate
US4167562A (en) * 1978-08-28 1979-09-11 Evers H Ray Method and composition for treating arteriosclerosis
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
US4898879A (en) * 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (enExample) * 1983-04-05 1987-06-27 Scras
US4515771A (en) * 1983-04-11 1985-05-07 Fine Daniel H Composition and method for the preventative treatment of dental disease and apparatus for dispensing said composition
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US4605741A (en) * 1985-11-13 1986-08-12 Lisapharma Spa Pharmaceutically active salt derivative of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphate
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
US5631271A (en) * 1986-11-29 1997-05-20 Serfontein; Willem J. Methods and preparations for the treatment and prophylaxis of metabolic disturbances
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US5213813A (en) * 1987-05-29 1993-05-25 The University Of Vermont Pyridoxal-5'-phosphate as an in vitro blood platelet stabilizer
EP0326034B1 (de) * 1988-01-28 1992-08-26 Peter Dr. Költringer Kombinationspräparat zur Behandlung von Nervenzell-und Nervenfasererkrankungen und Verletzungen
US5088977A (en) * 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5001115A (en) * 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
JPH06507902A (ja) * 1991-05-15 1994-09-08 エール・ユニバーシティ 肝臓で代謝される薬物前駆物の決定とその治療的利用
FR2678622B1 (fr) * 1991-07-03 1994-11-18 Adir Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993013660A1 (en) * 1992-01-06 1993-07-22 Health Maintenance Programs, Inc. Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty
US5420112A (en) * 1992-06-12 1995-05-30 Lewis; Michael E. Prevention and treatment of peripheral neuropathy
ES2140463T3 (es) * 1992-06-12 2000-03-01 Cephalon Inc Prevencion y tratamiento de la neuropatia periferica.
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
US5795873A (en) * 1992-12-29 1998-08-18 Metabolite Laboratories, Inc. Method for treatment and prevention of deficiencies of vitamins B12, folic acid and B6
TW268948B (enExample) * 1993-04-02 1996-01-21 Senju Pharma Co
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
US5733916A (en) * 1995-03-24 1998-03-31 The Trustees Of The University Of Pennsylvania Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
US5874443A (en) * 1995-10-19 1999-02-23 Trega Biosciences, Inc. Isoquinoline derivatives and isoquinoline combinatorial libraries
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5874420A (en) * 1995-12-26 1999-02-23 Allegheny University Of The Health Sciences Process for regulating vagal tone
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
US5944020A (en) * 1997-02-25 1999-08-31 Cypros Pharmaceutical Corp. Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery
US5888514A (en) * 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
EP1078917A4 (en) * 1998-02-17 2002-11-06 Ono Pharmaceutical Co AMIDINO DERIVATIVES FOR USE AS ACTIVE INGREDIENTS AND MEDICINES CONTAINING THEM
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6274170B1 (en) * 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
BR0008857A (pt) * 1999-03-08 2001-12-18 Medicure Inc Análogos de piridoxal para distúrbios da vitaminab-6
US6677356B1 (en) * 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
PT1268498E (pt) * 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
AU784840B2 (en) * 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
ATE364595T1 (de) * 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) * 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
EP1610783A2 (en) * 2003-03-27 2006-01-04 Medicure Inc. Modulation of cell death
AU2004224566A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
CN101014357A (zh) * 2004-07-07 2007-08-08 麦迪库瑞国际公司 利用血小板聚集药物的组合疗法
CN101035543A (zh) * 2004-08-10 2007-09-12 麦迪库瑞国际公司 维生素b6相关化合物与ace抑制剂的联合疗法及其治疗糖尿病病症的用途
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US7812037B2 (en) * 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
CA2593793A1 (en) * 2005-01-05 2006-07-13 Medicure International Inc. Compounds and methods for regulating triglyceride levels

Similar Documents

Publication Publication Date Title
JP2009517411A5 (enExample)
JP2005515966A5 (enExample)
JP2013511507A5 (enExample)
JP2009102342A5 (enExample)
JP2009514874A5 (enExample)
JP2018514534A5 (enExample)
JP2004534057A5 (enExample)
JP2013542247A5 (enExample)
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
JP2011522816A5 (enExample)
JP2005537268A5 (enExample)
CN101073563B (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
JP2006527256A5 (enExample)
JP2008543936A5 (enExample)
JP2021073257A5 (enExample)
JP2002534477A5 (enExample)
JP2006503095A5 (enExample)
RU2004127128A (ru) Фармацевтическая композиция для регенерации цирротической печени
WO2005065664A8 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
RU2007132971A (ru) Способы и материалы с транс-кломифеном для лечения мужского бесплодия
JP2005515155A5 (enExample)
JP2020536098A5 (enExample)
JP2007504223A5 (enExample)